Sevelamer Carbonate
Product manufactured by Wilshire Pharmaceuticals, Inc.
Indications and Purposes
| 1 Indications And Usage Sevelamer Carbonate Tablets Are Indicated For The Control Of Serum Phosphorus In Adults With Chronic Kidney Disease (Ckd) On Dialysis. Pediatric Use Information Is Approved For Genzyme Corporation's Renvela (Sevelamer Carbonate) Tablets And Renvela (Sevelamer Carbonate) For Oral Suspension. However, Due To Genzyme Corporation's Marketing Exclusivity Rights, These Drug Products Are Not Labeled With That Pediatric Information. Sevelamer Carbonate Tablets Are A Phosphate Binder Indicated For The Control Of Serum Phosphorus In Adults With Chronic Kidney Disease On Dialysis. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Sevelamer Carbonate |
|
ZINC2016052 |